Recombinant TNFSF11 (Denosumab Biosimilar) antibody
Research Grade
Reactivity: Human
Host: Mammalian Cells
Monoclonal
unconjugated
Recombinant Antibody
-
-
Target
See all TNFSF11 (Denosumab Biosimilar) products
-
TNFSF11 (Denosumab Biosimilar)
-
Antibody Type
-
Recombinant Antibody
-
Reactivity
-
Human
-
Host
-
Mammalian Cells
-
Expression System
-
Mammalian cells
-
Clonality
-
Monoclonal
-
Conjugate
-
This TNFSF11 (Denosumab Biosimilar) antibody is un-conjugated
-
Application
-
Please inquire
-
Purpose
-
Denosumab Biosimilar - Anti-RANKL mAb
-
Characteristics
-
Antibody Type: IgG2Kappa
-
Purification
-
Recombinant antibody expressed in mammalien cells and purified.
-
Grade
-
Research Grade
-
Isotype
-
IgG2 kappa
-
-
-
Restrictions
-
For Research Use only
-
-
Buffer
-
PBS buffer pH 7.5
-
Storage
-
4 °C,-20 °C
-
Storage Comment
-
4°C for short term, -20°C for long term
-
-
Target
-
TNFSF11 (Denosumab Biosimilar)
-
Alternative Name
-
RANKL (Denosumab Biosimilar) (TNFSF11 (Denosumab Biosimilar) Products)
-
Synonyms
-
CD254 antibody, ODF antibody, OPGL antibody, OPTB2 antibody, RANKL antibody, TRANCE antibody, hRANKL2 antibody, sOdf antibody, TNF superfamily member 11 antibody, TNFSF11 antibody
-
Target Type
-
Biosimilar
-
Background
-
Denosumab
-